Adrienne Asch: A Career at the Intersection of Bioethics and Disability Studies
By Sara Bergstresser,
Voices in Bioethics
| 03. 12. 2014
The first time I heard Adrienne Asch speak, she had assumed her role as a respected and influential member of the Disability Studies field. Later, as a student of Bioethics, I discovered that she was also a respected and influential Bioethicist. Who was this scholar with such expertise in two fields, and why did her contribution to each field have to be discovered separately? Asch passed away in November of 2013. Widely missed and memorialized in these two fields, I realized that there must be a third form of recognition for her pioneering work at the intersection of Disability Studies and Bioethics.
Asch was born in New York in 1946. Born premature, she developed retinopathy from too much oxygen in her incubator, thus losing her vision (Roberts 2013). Asch’s own difficulty in finding employment after graduating from Swarthmore College with a Bachelor’s degree in Philosophy made her keenly aware of disability as a civil rights issue (Fox 2013). She went on to study Social Work and Social Psychology at Columbia University and in 2005, she was recruited to direct the...
Related Articles
By Abby Vesoulis, Mother Jones | 04.18.2026
Two years ago, we devoted an entire issue to the rise of the American oligarchy. Since then, our oligarchic system has become more entrenched and pervasive, revolving around a small crew of tech titans whose quest for wealth and...
By Miguel Muñoz, Cadena SER [cites Marcy Darnovsky] | 08.04.2026
"Para ellos, una familia numerosa no solo es una preferencia personal, sino que es una obligación. Creen que tener tantos hijos como sea posible es necesario para evitar un futuro apocalíptico", aseguraba Xavier Orri, periodista y cofundador de Página Internacional...
By Ryan Cross, Endpoints News | 03.24.2026
Cathy Tie has an audacity more typical of a tech startup founder than a biotech executive. She dropped out of college to start a genetic screening company and later founded a telemedicine startup. The 29-year-old has been on two Forbes...
By Alex Polyakov, The Conversation | 02.09.2026
Prospective parents are being marketed genetic tests that claim to predict which IVF embryo will grow into the tallest, smartest or healthiest child.
But these tests cannot deliver what they promise. The benefits are likely minimal, while the risks to...